Blood Clot Plasmin Antigen Specific Localization In

نویسنده

  • L. AMBRUS
چکیده

I N PREVIOUS REPORTS1-3 various methods, including radiotracer studies, revealed the capacity of plasmin to adsorb selectively to preformed venous and arterial clots. Components of the fibrinolysin system were labeled with iodine131 and their distribution studied following intravenous administration. The highest degree of adsorption to fibrin clots was exhibited by human plasminogen activated with streptokinase ( SK ) or urokinase ( UK ) . Spontaneously activated human plasmin or chloroform-activated bovine plasmin exhibited less localizing capacity. The inactive precursor plasminogen also localized in clots to some extent. On the other hand, plasminogen activators as UK and SK given alone behaved as the radio-iodinated albumin control. Both experimentally and clinically,1’4#{176} clot lysis following plasmin infusion was found to proceed long after the disappearance of any measurable circulating fibrinolytic activity. Radioactivity measurement revealed the presence of a plasmin-antiplasmin complex which seems to release free plasmin to the fibin substrate. The studies with I’31-labeled plasmin preparations involve two sources of error. First, since even the purest plasmin preparations available at present contain various protein impurities, the danger exists that part of the 1131.. labeled material which was found to localize in fibrin clots actually represented impurities rather than plasmin itself. Second, it was shown1 that radioiodination alters enzymatic activities to some extent and what was measured actually was the distribution of partially denatured enzymes. For this reason it was decided to repeat these experiments using immunotiuorescent technics.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Streptokinase for Treatment of Thrombotic Disorders: The End? Or the End of the Beginning?

Thrombotic disorders, such as myocardial infarction, ischemic stroke, peripheral arterial disease, deep venous thrombosis, pulmonary embolism, or other embolic diseases that are responsible for worldwide mortality and morbidity, are manifestations of the formed thrombi by blood clots during a pathologic blood coagulation process. Once thrombi are formed, the only way to resolve the blood clot i...

متن کامل

The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor.

The pathogenesis of accelerated fibrinolysis in liver cirrhosis was investigated by comparing the results of specific assays for tissue plasminogen activator (tpa) antigen, tpa activity, tpa inhibitor, and alpha-2 plasmin inhibitor (a2PI) in 12 patients with cirrhosis and markedly accelerated fibrinolysis (dilute whole blood clot lysis time (DWBCLT) less than two hours), in nine patients with c...

متن کامل

Lumbrokinase – A Potent and Stable Fibrin–Specific Plasminogen Activator

Cardio and cerebrocascular disorders lead to about 26 million deaths every year around the world. Cardio and cerebrovaccular disorders have not only high mortality rate across the globe but also leading to subsequent complication such as thrombolysis could favorably influence the outcome of such life-threatening disorder as myocardial infarction, cerebrovascular thrombosis, and venous thromboem...

متن کامل

Comparison of local thrombolytic efficacy of plasmin and rt-PA in an in-vitro flow system; a pilot study.

Plasmin, a directly acting thrombolytic agent, demonstrated a very favorable safety profile upon intra-arterial delivery to the clot site; however, its thrombolytic efficacy remains to be further assessed. In this study, differences in thrombolysis between clots exposed to equimolar concentrations of plasmin and recombinant tissue-type plasminogen activator (rt-PA) after partial vessel recanali...

متن کامل

Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.

BACKGROUND Although plasminogen activator therapy has been shown to reduce mortality in patients with severe myocardial infarction, several problems fuel the search for more potent and specific thrombolytic agents. METHODS AND RESULTS To explore the effect of plasminogen activator targeting to platelets, we covalently linked urokinase that had been modified with N-succinimidyl-3-(2-pyridyldit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005